Literature DB >> 19172284

Long-term success rate after surgical treatment of anorectal and rectovaginal fistulas in Crohn's disease.

Thorsten Löffler1, Thilo Welsch, Stefanie Mühl, Ulf Hinz, Jan Schmidt, Peter Kienle.   

Abstract

BACKGROUND: Due to the considerable variety in the clinical presentation of anorectal and rectovaginal fistulas in Crohn's disease, data on treatment results for each type of fistula are limited. The aim of this study was to summarize the results after surgical treatment of such fistulas in a large consecutive series of patients. PATIENTS AND METHODS: All patients with anorectal or rectovaginal fistula due to Crohn's disease requiring surgery in our institution between 1991 and 2001 were extracted from a prospective database. A standardized telephone interview was conducted and patients were followed in our outpatient clinic, the department of internal medicine, or at their gastroenterologist. Type of fistula and interventions were classified and analyzed. Recurrence-free time intervals were estimated for each type of fistula and for the different surgical procedures. The influence of the surgical procedure, the number of operations performed, and the correlation to other localizations of the disease were analyzed in regard to the recurrence rate.
RESULTS: From 777 patients with Crohn's disease undergoing surgery between 1991 and 2001, 147 had anorectal or rectovaginal fistula (292 operations). Ninety-eight percent of them also had Crohn's disease in the colon or rectum compared to only 21% of patients without a fistula (p value <0.001). Over long-term follow-up, 29 patients (20%) required proctectomy. Submucosal fistulas needed major surgery in only 14% of cases compared to 56% of cases with rectovaginal fistulas. After 5 years, complex fistulas showed a strong trend towards a higher recurrence rate after surgery than simple submucosal fistulas (45.6% vs. 18.8%, p = 0.079). Whereas recurrences occurred over the whole observation period in the group of patients with complex fistulas, there was no further recurrence in patients with submucosal fistulas 13 months after surgery. In rectovaginal fistulas, additional levatorplasty showed no advantage over standard endorectal advancement flap.
CONCLUSIONS: Long-term follow-up demonstrates that recurrence rates after repair of complex fistulas for Crohn's disease are high and continuously increase over time. Submucosal fistulas have the best outcome; after 13 months without recurrence, definite cure can be expected.

Entities:  

Mesh:

Year:  2009        PMID: 19172284     DOI: 10.1007/s00384-009-0638-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  31 in total

1.  The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.

Authors:  David A Schwartz; Edward V Loftus; William J Tremaine; Remo Panaccione; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

2.  A classification of fistula-in-ano.

Authors:  A G Parks; P H Gordon; J D Hardcastle
Journal:  Br J Surg       Date:  1976-01       Impact factor: 6.939

3.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

4.  Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients.

Authors:  A Lapidus; O Bernell; G Hellers; R Löfberg
Journal:  Gastroenterology       Date:  1998-06       Impact factor: 22.682

5.  Long-term analysis of the use of transanal rectal advancement flaps for complicated anorectal/vaginal fistulas.

Authors:  G Ozuner; T L Hull; J Cartmill; V W Fazio
Journal:  Dis Colon Rectum       Date:  1996-01       Impact factor: 4.585

6.  Surgical treatment of anorectal complications in Crohn's disease.

Authors:  F Michelassi; M Melis; M Rubin; R D Hurst
Journal:  Surgery       Date:  2000-10       Impact factor: 3.982

7.  Long-term healing of Crohn's anal fistulas with fibrin glue injection.

Authors:  V Vitton; M Gasmi; M Barthet; A Desjeux; P Orsoni; J C Grimaud
Journal:  Aliment Pharmacol Ther       Date:  2005-06-15       Impact factor: 8.171

8.  Progression and prognosis of Crohn's colitis.

Authors:  F Makowiec; C Schmidtke; D Paczulla; R Lamberts; H D Becker; M Starlinger
Journal:  Z Gastroenterol       Date:  1997-01       Impact factor: 2.000

9.  The initial approach to anorectal abscesses: fistulotomy is safe and reduces the chance of recurrences.

Authors:  W T Knoefel; S B Hosch; B Hoyer; J R Izbicki
Journal:  Dig Surg       Date:  2000       Impact factor: 2.588

10.  Clinical course of perianal fistulas in Crohn's disease.

Authors:  F Makowiec; E C Jehle; M Starlinger
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

View more
  16 in total

Review 1.  Managing Perianal Crohn’s Disease.

Authors:  Dawn M Wiese; David A Schwartz
Journal:  Curr Gastroenterol Rep       Date:  2012-04

Review 2.  Prognostic factors affecting outcomes in fistulating perianal Crohn's disease: a systematic review.

Authors:  G C Braithwaite; M J Lee; D Hind; S R Brown
Journal:  Tech Coloproctol       Date:  2017-06-20       Impact factor: 3.781

Review 3.  Imaging techniques and combined medical and surgical treatment of perianal Crohn's disease.

Authors:  F Botti; A Losco; C Viganò; B Oreggia; M Prati; E Contessini Avesani
Journal:  J Ultrasound       Date:  2013-10-24

4.  Sphincter-sparing intersphincteric rectal resection as an alternative to proctectomy in long-standing fistulizing and stenotic Crohn's proctitis?

Authors:  Nicolas Schlegel; Mia Kim; Joachim Reibetanz; Katica Krajinovic; Christoph-Thomas Germer; Christoph Isbert
Journal:  Int J Colorectal Dis       Date:  2015-04-08       Impact factor: 2.571

5.  Similar outcomes for anti-tumor necrosis factor-α antibody and immunosuppressant following seton drainage in patients with Crohn's disease-related anal fistula.

Authors:  Xutao Lin; Dejun Fan; Zerong Cai; Lei Lian; Xiaowen He; Min Zhi; Xiaojian Wu; Xiaosheng He; Ping Lan
Journal:  Exp Ther Med       Date:  2016-07-26       Impact factor: 2.447

Review 6.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.

Authors:  G Pellino; D S Keller; G M Sampietro; I Angriman; M Carvello; V Celentano; F Colombo; F Di Candido; S Laureti; G Luglio; G Poggioli; M Rottoli; S Scaringi; G Sciaudone; G Sica; L Sofo; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-14       Impact factor: 3.781

Review 7.  Recent advances in the management of perianal fistulizing Crohn's disease: lessons for the clinic.

Authors:  Nicole Lopez; Sonia Ramamoorthy; Willam J Sandborn
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2019-04-26       Impact factor: 3.869

Review 8.  The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel disease.

Authors:  Michael Scharl; Ramona S Bruckner; Gerhard Rogler
Journal:  United European Gastroenterol J       Date:  2016-02-19       Impact factor: 4.623

9.  Video-assisted anal fistula treatment (VAAFT) combined with advancement flap repair in Crohn's disease.

Authors:  O Schwandner
Journal:  Tech Coloproctol       Date:  2012-11-23       Impact factor: 3.781

Review 10.  Management of Perianal Fistulas in Crohn's Disease.

Authors:  Steffen Seyfried; Alexander Herold
Journal:  Visc Med       Date:  2019-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.